Concepedia

Publication | Closed Access

A Prospective Open-Label Trial of Extended-Release Carbamazepine Monotherapy in Children with Bipolar Disorder

83

Citations

41

References

2010

Year

Abstract

Open-label CBZ-ER treatment was beneficial for the treatment of BD in children. Future controlled trials are warranted.

References

YearCitations

Page 1